Male Breast Carcinoma — Trials

Male Breast Carcinoma — Trials · CancerIndex

Clinical trials

Registered studies

104 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 4
Recruiting: 2
Ph III recruiting: 0
Growth YoY: —
Industry share: 0%
Top sponsor: H. Lee Moffitt Cancer Center and Research Institute
Termination share: 34%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (23)

clinicaltrialsPublishedShowing 101–104 of 104 studies · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT00017394	Bevacizumab Plus Vinorelbine in Treating Patients With Stage IV Breast Cancer	completed	Phase 2	56	National Cancer Institute (NCI)NIH	1	Jan 17, 2013	clinicaltrials
NCT00030498	Erlotinib in Treating Patients With Solid Tumors and Liver or Kidney Dysfunction	completed	Phase 1	75	National Cancer Institute (NCI)NIH	1	Jan 16, 2013	clinicaltrials